News
Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT HOW AM I GOING...
Read
A risk-based approach to clinical research may include a central statistical assessment of data quality.
Read
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance...
Read
Not only is there a significant good clinical practice (GCP) expectation, Risk-Based Monitoring (RBM)...
Read
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
Read
Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information...
Read
